Maria Pia Foschino Barbaro
Overview
Explore the profile of Maria Pia Foschino Barbaro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
117
Citations
962
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tondo P, Scioscia G, De Pace C, Murgolo F, Maci F, Stella G, et al.
Life (Basel)
. 2025 Jan;
15(1).
PMID: 39860046
Background: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease with a median survival of 3-5 years. Antifibrotic therapies like pirfenidone and nintedanib slow progression, but the outcomes vary....
2.
Baraldi F, Bigoni T, Foschino Barbaro M, Micheletto C, Scioscia G, Vatrella A, et al.
Monaldi Arch Chest Dis
. 2025 Jan;
PMID: 39810570
Mucus hypersecretion is a trait of chronic obstructive pulmonary disease (COPD) associated with poorer outcomes. As it may be present before airway obstruction, its early treatment may have a preventive...
3.
Perrotta F, Lacedonia D, DAgnano V, Bianco A, Scioscia G, Tondo P, et al.
Front Oncol
. 2025 Jan;
14:1488157.
PMID: 39741973
Background: Interstitial lung diseases (ILDs) comprise a family of heterogeneous entities, primarily characterised by chronic scarring of the lung parenchyma. Among ILDs, idiopathic pulmonary fibrosis (IPF) is the most common...
4.
Soccio P, Moriondo G, Scioscia G, Tondo P, Bruno G, Giordano G, et al.
Noncoding RNA Res
. 2024 Dec;
10:261.
PMID: 39737057
[This corrects the article DOI: 10.1016/j.ncrna.2024.09.008.].
5.
Tondo P, Scioscia G, Bailly S, Sabato R, Campanino T, Soccio P, et al.
Eur J Intern Med
. 2024 Dec;
133:64-70.
PMID: 39690003
Background: Obstructive sleep apnea (OSA) is a heterogeneous sleep disorder for which the identification of phenotypes might help for risk stratification for long-term mortality. Thus, the aim of the study...
6.
Scioscia G, Baraldi F, Bigoni T, Papi A, Vatrella A, Micheletto C, et al.
Respir Med
. 2024 Nov;
235:107865.
PMID: 39549856
Chronic obstructive pulmonary disease (COPD) is a progressive lung condition and a leading cause of physical decline and death. COPD prevalence is expected to increase steadily in the coming years,...
7.
Soccio P, Moriondo G, Scioscia G, Tondo P, Bruno G, Giordano G, et al.
Noncoding RNA Res
. 2024 Sep;
10:91-97.
PMID: 39315340
Introduction: The relationship between obstructive sleep apnea (OSA) and cancer has been recognized for some time now. However, little is known about the mechanisms by which sleep apnea promotes tumorigenesis...
8.
Crimi C, Nolasco S, Noto A, Maglio A, Quaranta V, Di Bona D, et al.
J Allergy Clin Immunol Pract
. 2024 Aug;
12(12):3315-3327.
PMID: 39197750
Background: Biological therapies, such as mepolizumab, have transformed the treatment of severe eosinophilic asthma. Although mepolizumab's short-term effectiveness is established, there is limited evidence on its ability to achieve long-term...
9.
Soccio P, Quarato C, Tondo P, Lacedonia D, Hoxhallari A, Foschino Barbaro M, et al.
Cells
. 2024 Aug;
13(16).
PMID: 39195245
Recent advancements in asthma management include non-invasive methodologies such as sputum analysis, exhaled breath condensate (EBC), and fractional exhaled nitric oxide (FeNO). These techniques offer a means to assess airway...
10.
Scioscia G, Santacroce R, Tondo P, Hoxhallari A, Soccio P, Giuffreda E, et al.
Arch Bronconeumol
. 2024 Jun;
60(9):595-597.
PMID: 38876920
No abstract available.